Trajan Group Holdings Limited (TRJNF)
OTCMKTS · Delayed Price · Currency is USD
0.5000
-0.0800 (-13.79%)
At close: Jun 4, 2025
Trajan Group Holdings Revenue
In the fiscal year ending June 30, 2025, Trajan Group Holdings had annual revenue of 166.46M AUD with 7.38% growth. Trajan Group Holdings had revenue of 85.46M in the half year ending June 30, 2025, with 4.10% growth.
Revenue
166.46M AUD
Revenue Growth
+7.38%
P/S Ratio
0.73
Revenue / Employee
256.10K AUD
Employees
650
Market Cap
79.27M USD
Revenue Chart
* This company reports financials in AUD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2025 | 166.46M | 11.44M | 7.38% |
Jun 30, 2024 | 155.02M | -7.13M | -4.40% |
Jun 30, 2023 | 162.15M | 54.58M | 50.74% |
Jun 30, 2022 | 107.57M | 31.01M | 40.49% |
Jun 30, 2021 | 76.57M | 4.72M | 6.56% |
Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Veradigm | 588.02M |
Elite Pharmaceuticals | 105.45M |
Tian'an Technology Group | 2.12M |
Glass House Brands | 221.55M |
Northwest Biotherapeutics | 1.09M |
American Oncology Network | 1.76B |
Silence Therapeutics | 27.17M |
AMJ Global Technology | 39.00 |